Melatonin rescues 3T3-L1 adipocytes from FFA-induced insulin resistance by inhibiting phosphorylation of IRS-1 on Ser307

Biochimie. 2014 Aug:103:126-30. doi: 10.1016/j.biochi.2014.05.001. Epub 2014 May 15.

Abstract

Melatonin is biosynthesized in the pineal gland and secreted into the bloodstream. Evidences indicate a role of melatonin in the regulation of glucose metabolism. The objective of this study was to investigate the effect of melatonin on insulin sensitivity in insulin resistant adipocytes. Following a preincubation with melatonin or vehicle for 30 min, insulin resistant cells of 3T3-L1 adipocytes were induced by palmitic acids (300 μM, 6 h). Our results showed that palmitic acids inhibited both the basal and insulin-stimulated uptake of [(3)H]-2-Deoxyglucose, down-regulated the levels of IRS-1 and GLUT-4. However, compared to the vehicle group, melatonin pre-treatment increased significantly the uptake of [(3)H]-2-Deoxyglucose as well as the level of GLUT-4, and decreased phosphorylated IRS-1 (Ser307) although total IRS-1 did not change significantly. These data suggest that palmitic acids impair insulin signal via down-regulating the expressions of IRS-1 and GLUT-4; whereas melatonin can ameliorate insulin sensitivity by inhibiting Ser307 phosphorylation in IRS-1 and increasing GLUT-4 expressions in insulin resistant 3T3-L1 adipocytes. We conclude that melatonin regulates the insulin sensitivity and glucose homeostasis via inhibiting Ser-phosphorylation and improving function of IRS-1.

Keywords: 3T3-L1 adipocytes; Glucose uptake; Insulin sensitivity; Melatonin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells
  • Adipocytes / drug effects*
  • Adipocytes / metabolism*
  • Animals
  • Biological Transport / drug effects
  • Gene Expression Regulation / drug effects
  • Glucose / metabolism
  • Glucose Transporter Type 4 / metabolism
  • Insulin Receptor Substrate Proteins / chemistry
  • Insulin Receptor Substrate Proteins / metabolism*
  • Insulin Resistance*
  • Melatonin / pharmacology*
  • Mice
  • Palmitic Acid / adverse effects*
  • Phosphorylation / drug effects
  • Serine / metabolism*

Substances

  • Glucose Transporter Type 4
  • Insulin Receptor Substrate Proteins
  • Irs1 protein, mouse
  • Palmitic Acid
  • Serine
  • Glucose
  • Melatonin